期刊文献+

肥胖大鼠血清C反应蛋白水平的动态变化及罗格列酮干预的影响 被引量:2

Dynamic changes of serum C-reaction protein levels in diet-induced obese rats and effect of rosiglitazone intervention
下载PDF
导出
摘要 目的 观察高脂喂养的肥胖大鼠模型胰岛素抵抗出现的时间、程度的变化及C反应蛋白 (CRP)水平的动态变化 ;观察罗格列酮对高脂肥胖大鼠血清CRP水平的影响。方法  3 0只清洁级雄性Wistar大鼠按体重随机分成正常对照组、肥胖组和罗格列酮治疗组。肥胖组和治疗组以高脂饮食喂养 2 0周 ,制成肥胖模型。于实验过程的第 10、2 0、2 4周分别取血检测空腹血糖、空腹胰岛素和血清CRP。CRP检测用免疫散射比浊法测定。结果 与正常对照组比较 ,高脂喂养大鼠第10周已出现胰岛素抵抗 ,并逐渐加重。同时 ,肥胖组血清CRP水平也逐渐升高 ,第 2 0周明显高于第 10周 (P <0 .0 5 )。至 2 4周 ,肥胖组、治疗组大鼠血清CRP水平明显高于正常组 (分别为P <0 .0 1,P <0 .0 5 ) ,治疗组低于肥胖组 (P <0 .0 5 )。血清CRP水平与胰岛素敏感性指数、甘油三酯呈正相关关系 (r =0 .3 5 9,P <0 .0 5 ;r =0 .482 ,P <0 .0 1)。结论 随着胰岛素抵抗的加重 ,血清CRP水平逐渐升高 ,罗格列酮治疗可改善胰岛素抵抗 。 Objective To observe dynamic changes of insulin resistance,serum C-reaction protein levels in diet-induced obese rats and effect of rosiglitazone intervention.Methods Thirty SPF level Wistar male rats of age 2-3 weeks were divided into 3 group randomly:the normal control group,fat group and the rosiglitazone-treatment fat group.After 20 weeks high fat diet feeding get fat models.The serum CRP concentration was detected in the 10th,20th,24th week with immunoscattering assay.Results Insulin resistance of the fat-feed rats started in the 10th week,and increased gently.At the same time,the serum CRP increased with the insulin resistance.The serum CRP levels of fat group and rosiglitazone-treatment fat group in the 24th week were significantly higher than the normal control group(P<0.01,P< 0.05).The serum CRP levels in the rosiglitazone-treatment fat group were decreased(P<0.05).The serum CRP concentration was positively correlated with insulin sensitivity index(r=-0.359,P<0.05),Triglyceride(r=0.482,P<0.01).Conclusion The serum CRP concentration gradually increased with worsening of insulin resistance.Rosiglitazone improved insulin resistance,decreased the serum CRP levels.
出处 《临床内科杂志》 CAS 北大核心 2004年第8期561-563,共3页 Journal of Clinical Internal Medicine
关键词 C反应蛋白 肥胖 胰岛素抵抗 罗格列酮 C-reaction protein Obesity Insulin resistance Rosiglitazone
  • 相关文献

参考文献6

  • 1Schmidt MI,Duncan BB,scharrct AR,et al.Markers of inflammation and prediction of diabetes mellitus in adults ( Atherosclerosis Risk in Communities study):a cohort study.Lancet,1999,353 (9165):1649-1652.
  • 2Barzilay JI,Abraham L,Heckbert SR,et al.The relation of markers of inflammation to the development of glucose disorders in the elderly:the Cardiovascular Health Study.Diabetes,2001,50(10):2384-2389.
  • 3李光伟,陈燕燕,张景玲,王金平,郑辉,姜亚云,胡英华.胰岛素抵抗是糖耐量正常人群糖耐量恶化的最重要危险因素[J].中华内分泌代谢杂志,2000,16(2):74-77. 被引量:64
  • 4Ye JM,Doyle P J,Iglesias MA,et al.Peroxisome proliferators-activated receptor(PPAR)-α activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats:comparison with PPAR-γactivation.Diabetes,2001,50(2):411-417.
  • 5John A,Colwell MD.Inflammation and diabetic vascular complication.Diabetes Care,1999,22 (10):1927-1928.
  • 6Ebeling P,Teppo AM,Koistinen HA,et al.Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins with type Ⅱ diabetes.Diabetologia,1999,42 ( 12 ):1433-1438.

二级参考文献11

共引文献63

同被引文献32

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33041
  • 2Senn J J, Klover PJ, Nowak IA, et al. Suppressor of cytokine signaling-3 ( SOCS-3 ), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes [ J ]. J Biol Chem, 2003,278 (16) :13740-13746.
  • 3Krogh-Madsen R, Plomgaard P, Keller P, et al. Insulin stimulates interleukin-6 and tumor necrosis factor-alpha gene expression in human subcutaneous adipose tissue [ J ]. Am J Physiol Endocrinol Metab, 2004,286(2) :234-238.
  • 4Ruan H, Hacohen N, Golub TR, et al. Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activa- tion by TNF-alpha is obligatory [ J ]. Diabetes, 2002,1 (5) :1319- 1336.
  • 5Lagathu C, Bastard JP, Auclair M, et al. Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by msiglitazone [ J ]. Bioehem Biophys Res Cormnun, 2003,311(2) :372-379.
  • 6Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men[J]. N Engl J Med, 1997, 336(14) :973-979
  • 7Di Napoli M, Di Gianfilippo G, Sollecito A, et al. C - reactive protein and outcome after first- ever ischemic stroke[J ]. Stroke,2000, 31 ( 1 ): 238-239
  • 8Pasceri V, Chang JS, Willerson JT, et al. Modulation of C- reactive protein - mediated monocyte chemoattractant protein - 1 induction in human endothelial cells by anti - atherosclerosis drugs[J]. Circulation, 2001, 103(21) :2531-2534
  • 9Zwaka TP, Hombach V, Torzewski J. C - reactive protein - mediated low density lipoprotein uptake by macrophages:implications for atherosclerosis[J]. Circulation, 2001, 103(9): 1194-1197
  • 10Tohgi H, Konno S, Takahashi S, et al. Activated coagulation/fibrinolysis system and platelet function in acute thrombotic stroke patients with increased C - reactive protein levels [ J ]. Thromb Res, 2000, 100(5) :373-379

引证文献2

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部